Correlation of oxidative stress parameters and left ventricular geometry in patients with chronic heart failure
Abstract
Oxidative stress as one of the pathophysiological mechanisms involved in reduces myocardial contractility, stimulating the proliferation of cardiac fibroblasts and the activation of matrix metalloproteinases they lead to extracellular matrix remodeling. Left ventricular hypertrophy (LVH) is a well-known independent risk factor for cardiovascular events. The aim of this research was to determine the connection between the parameters of oxidative stress and left ventricular geometry indicators in patients with chronic heart failure
The study included 81 subjects diagnosed with heart failure and 68 subjects in control group. Parameters of myocardial morphology and left ventricular function were measured by echocardiography. Thiobarbituric acid reacting substances (TBARS) content, Advanced oxidation protein products (AOPP), total serum SH groups and catalase activity were performed in both groups. The results showed that there were significantly higher concentrations of TBARS, AOPP, and SH groups, in patients compared to controls (p <0.01) and higher concentration of TBARS in patients with concentric hypertrophy compared to patients with normal geometry (p <0.05). Correlation analysis showed a strong positive correlation between geometry parameters and myocardial function and TBARS and negative correlation between right ventricule and catalase activity.
The results of this study show that oxidative stress parameters are significantly elevated in patients with heart failure, and that concentrations of TBARS and AOPP, markers of lipid and protein oxidation, strongly correlate with left ventricular geometry parameters.References
(1) Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et al. Heart failure: preventing disease and death worldwide: Addressing heart failure. ESC Heart Failure 2014;1:4–25. https://doi.org/10.1002/ehf2.12005.
(2) Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure 2011;301:10. https://doi.org/10.1152/ajpheart.00554.2011
(3) Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, et al. Increased Oxidative Stress in Patients With Congestive Heart Failure n.d.;31:5.
(4) Nishiyama Y, Ikeda H, Haramaki N, Yoshida N, Imaizumi T. Oxidative stress is related to exercise intolerance in patients with heart failure. American Heart Journal 1998;135:115–20. https://doi.org/10.1016/S0002-8703(98)70351-5.
(5) Gao Wei Dong, Liu Yongge, Marban Eduardo. Selective Effects of Oxygen Free Radicals on Excitation-Contraction Coupling in Ventricular Muscle. Circulation 1996;94:2597–604. https://doi.org/10.1161/01.CIR.94.10.2597.
(6) Grieve D. Oxidative stress in heart failure More than just damage. European Heart Journal 2003;24:2161–3. https://doi.org/10.1016/j.ehj.2003.10.015.
(7) Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, et al. Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-α and Angiotensin II. Circulation 1998;98:794–9. https://doi.org/10.1161/01.CIR.98.8.794.
(8) Witko-Sarsat V, Gausson V, Nguyen A-T, Touam M, Drüeke T, Santangelo F, et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney International 2003;64:82–91. https://doi.org/10.1046/j.1523-1755.2003.00044.x.
(9) Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation. Annals of Internal Medicine 1999;130:461–70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002.
(10) Andreeva IL, Kožemjakin AL, Kiškun AA. Modification of the method of measurement of lipid peroxides in test with thiobarbituric acid. Lab Delo 1988:41–3.
(11) Ellman LG. Tissue sulphydril groups. Arch Biochem Biophys 1952:70–7.
(12) Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clinica Chimica Acta 1991;196:143–51. https://doi.org/10.1016/0009-8981(91)90067-M.
(13) Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–13. https://doi.org/10.1038/ki.1996.186.
(14) Feigenbaum H. Echocardiography. Fifth edition. Phila-delphia. Lee&Fabiger: 1994.
(15) Lorell B, Carabello B. Left ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation 2000; 102:470-9. https://doi.org/10.1161/01.cir.102.4.470
(16) Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings.Am J Cardiol 1986; 57:450-8. https://doi.org/ 10.1016/0002-9149(86)90771-x
(17) Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.. J AM Soc Echocardiogr 2005; 18:1454-7. https://doi.org/ 10.1016/j.echo.2005.10.005
(18) McMurray J, Chopra M, Abdullah I, Smith WE, Dargie HJ. Evidence of oxidative stress in chronic heart failure in humans. European Heart Journal 1993;14:1493–8. https://doi.org/10.1093/eurheartj/14.11.1493.
(19) Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Heart 1991;65:245–8. https://doi.org/10.1136/hrt.65.5.245.
(20) Ide T, Tsutsui H, Kinugawa S, Suematsu N, Hayashidani S, Ichikawa K, et al. Direct Evidence for Increased Hydroxyl Radicals Originating From Superoxide in the Failing Myocardium. Circulation Research 2000;86:152–7. https://doi.org/10.1161/01.RES.86.2.152.
(21) Mitra S, Goyal T, Mehta JL. Oxidized LDL, LOX-1 and Atherosclerosis. Cardiovasc Drugs Ther 2011;25:419–29. https://doi.org/10.1007/s10557-011-6341-5.
(22) Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, et al. LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovascular Research 2009;84:127–36. https://doi.org/10.1093/cvr/cvp177.
(23) Koba S, Gao Z, Sinoway LI. Oxidative stress and the muscle reflex in heart failure: Tempol reduces sympathetic nerve response to contraction in HF. The Journal of Physiology 2009;587:5227–37. https://doi.org/10.1113/jphysiol.2009.177071.
(24) Zhou Q, Wu S, Jiang J, Tian J, Chen J, Yu X, et al. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients: AOPP and IHD in haemodialysis. Nephrology 2012;17:642–9. https://doi.org/10.1111/j.1440-1797.2012.01640.x.
(25) Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, et al. Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation. ATVB 2006;26:1156–62. https://doi.org/10.1161/01.ATV.0000214960.85469.68.
(26) Radovanovic S, Krotin M, Simic DV, Mimic-Oka J, Savic-Radojevic A, Pljesa-Ercegovac M, et al. Markers of oxidative damage in chronic heart failure: role in disease progression. Redox Report 2008;13:109–16. https://doi.org/10.1179/135100008X259204.
(27) Radovanovic S, Savic-Radojevic A, Pljesa-Ercegovac M, Djukic T, Suvakov S, Krotin M, et al. Markers of Oxidative Damage and Antioxidant Enzyme Activities as Predictors of Morbidity and Mortality in Patients With Chronic Heart Failure. Journal of Cardiac Failure 2012;18:493–501. https://doi.org/10.1016/j.cardfail.2012.04.003.
(28) Díaz-Vélez CR, García-Castiñeiras S, Mendoza-Ramos E, Hernández-López E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. American Heart Journal 1996;131:146–52. https://doi.org/10.1016/S0002-8703(96)90063-0.
(29) Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, et al. Oxidative Stress–Mediated Cardiac Cell Death Is a Major Determinant of Ventricular Dysfunction and Failure in Dog Dilated Cardiomyopathy. Circulation Research 2001;89:279–86. https://doi.org/10.1161/hh1501.094115.
(30) Singh N, Dhalla AK, Seneviratne C, Singal PK. Oxidative stress and heart failure. Mol Cell Biochem 1995;147:77–81. https://doi.org/10.1007.
(31) Amir O, Paz H, Rogowski O, Barshai M, Sagiv M, Shnizer S, et al. Serum Oxidative Stress Level Correlates with Clinical Parameters in Chronic Systolic Heart Failure Patients. Clin Cardiol 2009;32:199–203. https://doi.org/10.1002/clc.20317.
(32) Karabacak M, Dogan A, Tayyar S, Bas HA. Oxidative Stress Status Increase in Patients with Nonischemic Heart Failure. Med Princ Pract 2014;23:532–7. https://doi.org/10.1159/000365512.
(33) Ng LL, Pathik B, Loke IW, Squire IB, Davies JE. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. American Heart Journal 2006;152:94–101. https://doi.org/10.1016/j.ahj.2005.09.020.
(34) Szczurek W, Szyguła-Jurkiewicz B. Oxidative stress and inflammatory markers – the future of heart failure diagnostics? Kardiochir Torakochirurgia Pol 2015;2:145–9. https://doi.org/10.5114/kitp.2015.52856.